We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Oxford Nanopore Technologies Logo

Oxford Nanopore Technologies

Oxford Nanopore has developed a new generation of DNA/RNA sequencing technology. It is the only sequencing technology that offers real-time analysis in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths.

Latest Oxford Nanopore Technologies Content

A scientist pipettes liquid into a device attached to a laptop.

Compact DNA Sequencers Monitor Malaria Drug Resistance in Near Real-Time

Scientists have developed a technique to rapidly and reliably detect genetic changes in malaria parasites in Ghana, using just a gaming laptop and portable sequencer.
Vials of blood.
Product News

Oxford Nanopore and Day Zero Diagnostics Partner To Develop a New Class of Bloodstream Infection Diagnostics

Oxford Nanopore, and Day Zero Diagnostics (DZD), announced a collaboration to develop an end-to-end solution for the diagnosis of bloodstream infections, a leading cause of sepsis.
The letters of the DNA bases.
Product News

Oxford Nanopore To Showcase What You’re Missing Matters When Investigating Disease Enabled by Nanopore Sequencing

Our packed agenda will highlight how the Oxford Nanopore platform can generate richer data revealing enhanced biological insights not possible with short read sequencing – or other sequencing platforms – to accelerate research into human disease.
Double helix structure of DNA.
Product News

Oxford Nanopore Technologies and Fabric Genomics Collaborate To Launch an Integrated Whole-Genome Sequencing Solution

The partners will offer an integrated sample-to-report rapid nanopore sequencing analysis platform for neonatal/paediatric intensive care units to support clinicians in acute settings.
The corner of a macbook.
Product News

Oxford Nanopore Meets Apple’s M3 Silicon Chip

CEO Gordon Sanghera discusses how Apple’s latest product announcement means complex processing required for DNA/RNA sequencing can now be run from the latest MacBook Pro™ or iMac ™.
The letters representing the DNA bases.
Product News

bioMérieux Makes Strategic Investment in Oxford Nanopore

Oxford Nanopore Technologies, announce that bioMérieux is making an immediate £70M investment in Oxford Nanopore.
A hand holding an Eppendorf tube with the letters representing DNA bases in the background.
Product News

Mayo Clinic and Oxford Nanopore Announce Collaboration

Joint development collaboration to bring leading-edge nanopore sequencing into clinical laboratories at Mayo Clinic to increase understanding and improve treatment of cancer and genetic disorders.
A bat flying.

Bats’ Genomes Protect Them From Viruses and Cancer

Bats have acquired remarkable traits throughout their evolution. But perhaps most impressive is their robust immune system. It protects bats from viruses that wreak havoc in humans, like COVID-19 or Ebola.
Oxford Nanopore

Parent-of-Origin Genome Analysis: The Potential To Improve Genetic Testing

This webinar will introduce a novel method for parent-of-origin-aware genomic analysis using the long-read capabilities of nanopore sequencing and single-cell DNA template strand sequencing to assign variants to each biological parent with 99% accuracy using only a blood research sample from the child.
Cancer Cell Target
App Note / Case Study

Discover the Future of Cancer Research With Whole-Genome Sequencing

To accelerate the discovery of new cancer biomarkers and new insights into the genetics of treatment-resistant tumors, it is crucial to gain a deeper understanding of the genomic and epigenomic variations in cancer.